IVW-1001

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameIVW-1001
Drug Alias NameIVW-1001iVIEW-1001(IVIEW Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily M member 8 stimulants
TargetsTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsDry Eye SyndromesXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaIND
Originator CompaniesAiwei Pharmaceutical (Zhuhai) Co LtdIview Therapeutics Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesIview Therapeutics IncAiwei Pharmaceutical (Zhuhai) Co Ltd
Inactive CompaniesN/A
Active IndicationsDry Eye SyndromesXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A